Animal Models Used in Cutaneous Pharmacology

  • Martine Bouclier
  • Christopher N. Hensby
  • Daniel Cavey
Part of the NATO ASI Series book series (NSSA, volume 181)


The use of experimental models in cutaneous pharmacology has gained significant importance in recent years. There has been increasing interest in the use of experimental models to investigate the pathophysiology of diseases as well as potential responses to therapeutic agents.


Arachidonic Acid Sebaceous Gland Epidermal Hyperplasia Passive Cutaneous Anaphylaxis Ornithine Decarboxylase Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    C.V. Winder, J. Wax, V. Burr, M. Been, and CE. Rosiere, A study of pharmacological influence on ultraviolet erythema in guinea pigs, Archs Int Pharmacodyn Ther. 116:216–292 (1958)Google Scholar
  2. 2.
    D.S. Snyder, Cutaneous effects of topical indomethacin, an inhibitor of prostaglandin synthesis on UV damaged skin, J Invest Dermatol. 64:322–325 (1975)PubMedCrossRefGoogle Scholar
  3. 3.
    P. Peters, C. Cooper, K. Maiorana, and M.C. Graeme, The effect of topically applied agents on ultraviolet erythema in guinea pigs, Agents Actions. 7:545–553 (1977)PubMedCrossRefGoogle Scholar
  4. 4.
    E. Law, and A.J. Lewis, the effect of systemically and topically applied drugs on ultraviolet induced erythema in the rat, Br J Pharmacol. 59:591–597 (1977)PubMedGoogle Scholar
  5. 5.
    R.L. Bronaugh, R.G. Roller, and R. Cargill, The evaluation of topical anti-inflammatory activity on rat ears subjected to thermal injury, J Invest Dermatol. 71:263–265 (1978)PubMedCrossRefGoogle Scholar
  6. 6.
    E.G. Weirich, J.K. Longauer, and A.A. Kirkwood, New experimental model for the primary evaluation of topical contra-inflammatory agents, Arch Dermatol Res. 259:141–149 (1977)PubMedCrossRefGoogle Scholar
  7. 7.
    C.A. Schlagel, Corticosteroids: animal models and topical therapeutic utility, in: Animal Models in Dermatology, pp 203–211, Maibach ed. I, Churchill Livingstone, New York, (1975)Google Scholar
  8. 8.
    O.J. Lorenzetti, Animal to clinical correlation of topical anti-inflammatory efficacy of glucocorticosteroids, in: Animal Models in Dermatology, pp 215–225, Maibach ed. I, Churchill Livingstone, New york (1975)Google Scholar
  9. 9.
    G. Tonelli, L. Thibault, and I. Ringler, A bio-assay for the concomitant assessment of the antiphlogistic and thymolytic activities of topically applied corticoids, Endocrinology, 77:625–634 (1965)PubMedCrossRefGoogle Scholar
  10. 10.
    K.F. Swingle, M.J. Reiter, and D.H. Schwartzmiller, Comparison of croton oil and cantharidin induced inflammations of the mouse ear and their modification by topically applied drugs, Arch Int Pharmacodyn Ther., 254:168–176 (1981)PubMedGoogle Scholar
  11. 11.
    A. Tubaro, P. Dri, G. Delbello, C. Zilli, and R. Delia Loggia, The croton oil ear test revisited, Agents Actions, 17:347–349 (1985)CrossRefGoogle Scholar
  12. 12.
    A. Boris, and J.F. Hurley, Assessment of topical antiinflammatory activity in rats with cantharidin induced inflammation, J Invest Dermatol., 68:161–164 (1977)PubMedCrossRefGoogle Scholar
  13. 13.
    J.P. Tarayre, M. Aliaga, M. Barbara, G. Villanova, V. Caillol, and H. Lauressergues, Pharmacological study of cantharidin induced ear inflammation in mice, J Pharmacol Method. 11:271–277 (1984)CrossRefGoogle Scholar
  14. 14.
    J.M. Young, D.A. Spires, C.J. Bedord, B. Wagner, S.J. Ballaron, and L.H. Deyoung, The mouse ear inflammatory response to topical arachidonic acid, J Invest Dermatol. 82:367–371 (1984)PubMedCrossRefGoogle Scholar
  15. 15.
    J.L. Humes, E.E. Olas, and R.J. Bonney, Arachidonic acid metabolites in mouse ear oedema, in: Advances in Inflammation Research, pp 57–65, Otterness I., Lewis A., Capetola R. eds., Raven Press, New York (1986)Google Scholar
  16. 16.
    E.E. Opas, R.J. Bonney, and J.L. Humes, Prostaglandin and leukotriene synthesis in mouse ear inflammed by arachidonic acid, J Invest Dermatol. 84:253–256 (1985)PubMedCrossRefGoogle Scholar
  17. 17.
    E.C. Arner, B.L. Rule, M.S. Rudnick, and W. Galbraith, Arachidonic acid induced ear oedema, correlation of swelling with production of lipoxygenase (LO) products, Agents Actions, 16:600–601 (1985)Google Scholar
  18. 18.
    R.P. Carlson, L. O’Neill-Davis, J. Chang, and A.J. Lewis, Modulation of mouse ear oedema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents, Agents Actions, 17:197–204 (1985)PubMedCrossRefGoogle Scholar
  19. 19.
    A. Crummey, G.P. Harper, E.A. Boyle, and F.R. Mangan, Inhibition of arachidonic acid-induced ear oedema as a model for topical anti-iflammatory compounds, Agents Actions, 20:69–76 (1987)PubMedCrossRefGoogle Scholar
  20. 20.
    B. Luginbuhl, M. Bouclier, B. Shroot, and C. Hensby, Arachidonic acid induced ear oedema in three strains of rats and mice: a comparative study of anti-inflammatory drugs, Fundament Clin Pharmacol, in pressGoogle Scholar
  21. 21.
    D. Aker, S.J. Foster, M.E. Howarth, M.E. Mc Cormich, and H.C. Ports, The inflammatory response of rabbit skin to topical arachidonic acid and its pharmacological modulation, Br J Pharmacol. 89:431–438 (1986)Google Scholar
  22. 22.
    C.A. Winter, E.A. Risley, and G.W. Nuss, Carrageenin induced oedema in hind paw of the rat as an assay for anti-inflammatory drugs, Proc Soc Exp Biol Med. 111:544–547 (1962)PubMedGoogle Scholar
  23. 23.
    T.J. Williams, Mediation of increased vascular permeability after complement activation, J Exp Med. 153:136–153 (1981)PubMedCrossRefGoogle Scholar
  24. 24.
    M. Rampart, and T.J. Williams, Polymorphonuclear leucocyte dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration, Am J Pathol. 124:66–73 (1986)PubMedGoogle Scholar
  25. 25.
    S. Konno, and S. Tsurufuj, Induction of zymozan air pouch inflammation in rats and its characteristization with reference to the effects of anticomplementary and antiinflammatory agents, Br J Pharmacol. 80:269–272 (1983)PubMedGoogle Scholar
  26. 26.
    T.P. Gordon, I.C. Kowanko, and M. James, Monosodium urate crystal-induced prostaglandin synthesis in the rat subcutaneous air pouch, Clin Exp Rheumatol. 3:291–296 (1986)Google Scholar
  27. 27.
    A.D. Sedwick, and P. Lees, A comparison of air pouch, sponge and pleurisy models of acute carrageenan inflammation in the rat, Agents Actions, 18:439–446 (1986)CrossRefGoogle Scholar
  28. 28.
    S. Tsurufuji, Analysis of the action of anti-inflammatory drugs with the aid of various inflammatory models of subcutaneous pouch type, in: Advances in Inflammation Research, vol 10, pp 400–403, Russo Marie F., Mencia-Huerta J.M., Chignard M. eds., Raven Press, New York (1986)Google Scholar
  29. 29.
    A.W. Ford-Huchison, R.J. Walker, and M.J.H. Smith, assessment of anti-inflammatory activity by sponge implantation techniques, J Pharmacol Methods, 1:3–7 (1978)CrossRefGoogle Scholar
  30. 30.
    A.K. Clarke, B. Vernon-Roberts, and H.L.F. Currey, Assessment of anti-inflammatory drugs in the rat using subcutaneous implants of polyurethane foam impregnanted with dead tubercle bacili, Ann Rheum Dis. 34:326–331 (1975)PubMedCrossRefGoogle Scholar
  31. 31.
    J.M. Lackie, and A.F. Brown, Adhesion and locomotion of neutrophils on surfaces and in matrices, Agents Actions, (suppl 12):73–90 (1982)Google Scholar
  32. 32.
    R.B. Gilbertsen, G.W. Carter, and J. Quinn, Effects of F-Met-Leu-Phe and zymosan-activated serum on rat neutrophils in vivo, Reticuloendothel Soc. 27:485–494 (1980)Google Scholar
  33. 33.
    G.A. Higgs, Effects of anti-inflammatory drugs on arachidonic acid metabolism and leucocyte migration, in: Advances in Inflammation Research, vol 7, pp 223–238, Oterness I., Capetola R., Wong S. eds., Raven Press, New York (1984)Google Scholar
  34. 34.
    D.M. Mellor, D.B. Myers, and U.S. Chadwick, The cored sponge model of in vivo leucocyte Chemotaxis, Agents Actions, 18:550–554 (1986)PubMedCrossRefGoogle Scholar
  35. 35.
    G.G.I. Moore, and K.F. Swingle, 2,6-Di-tert-butyl-4-(2’-thenoyl) phenol (R-380): a novel nonsteroidal antiinflammatory agent with antioxidant properties, Agents Actions, 12:674–683 (1982)PubMedCrossRefGoogle Scholar
  36. 36.
    A.J. Crowle, and C.M. Crowle, Contact sensitivity in mice, J Allergy. 32:302–320 (1961)PubMedCrossRefGoogle Scholar
  37. 37.
    J.P. Tarayre, M. Aliaga, G. Villanova, M. Barbara, V. Caillol, M. Bru, and H. Lauressergues, Pharmacological comparison of the immune and non immune inflammation induced by picryl chloride and oxazolone in mice, Arch Int Pharmacodvn Ther. 269:153–166 (1984)Google Scholar
  38. 38.
    J.P. Tarayre, and H. Lauressergues, Modulation by various locally applied anti-inflammatory and anti-allergic compounds of the immune and non immune inflammation induced by picryl chloride in mice, Agents Actions, 12:662–770 (1982)PubMedCrossRefGoogle Scholar
  39. 39.
    M.B. Goldlust, and W.F. Schrieber, Use of the reversed passive Arthus reaction as a test for anti-inflammatory agents, Agents Actions, 5:39–47 (1975)PubMedCrossRefGoogle Scholar
  40. 40.
    B.A. Baldo, P.G. Thomas, C.L. Nelson, and K.M. Taylor, Passive paw anaphylaxis in the rat, Allergy, 35:399–408 (1980)PubMedCrossRefGoogle Scholar
  41. 41.
    N.S. Taichman, H.Z. Movat, M.F. Glynn, and I. Broder, Further sudies on the role of neutrophils in passive cutaneous anaphylaxis of the guinea-pig, Immunology, 21:623–635 (1971)PubMedGoogle Scholar
  42. 42.
    C. Delescluse, M.C. Bourin, G. Furstenberger, F. Marks and M. Prunieras, Diffrentiation modulates the response of guinea-pig epidermal keratinocytes to the stimulation of DNA synthesis by TPA, Differentiation, 20:87–91 (1981)PubMedCrossRefGoogle Scholar
  43. 43.
    M.C. Bourin, C. Delescluse, G. Furstenberger, F. Marks and M. Prunieras, Effect of Phorbol esters on guinea-pig skin in vivo, Carcinogenesis, 3:671–676 (1982)PubMedCrossRefGoogle Scholar
  44. 44.
    A.K. Verma, H.M. Rice, B.G. Shapas, and R.K. Boutwell, Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis by vitamin A analogues (retinoids), Cancer Res. 38:793–801 (1978)PubMedGoogle Scholar
  45. 45.
    N.J. Lowe, and J. Breeding, Retinoic acid modulation of ultraviolet light-induced epidermal ornithine decarboxylase activity, J Invest Dermatol, 78:121–124 (1982)PubMedCrossRefGoogle Scholar
  46. 46.
    M. Bouclier, B. Shroot, J. Eustache, and C.N. Hensby, A rapid and simple test system for the evaluation of the inhibitory activity of retinoids on induced ornithine decarboxylase activity in the hairless rat epidermis, J. Pharmacol Methods, 16:151–160 (1986)PubMedCrossRefGoogle Scholar
  47. 47.
    J. Schweizer, G. Furstenberger, H. Winter, Selective suppression of two postnatally acquired 70 Kd keratin proteins during continuous treatment of adult mouse tail epidermis with vitamin A, J Invest Dermatol. 89: 125–131 (1987)PubMedCrossRefGoogle Scholar
  48. 48.
    L.T. Ray, Animal models of experimental Candida infections of the skin, in: Models in Dermatology, vol 1, pp 41–50, Maibach, Lowe eds., Karger, Basel (1985)Google Scholar
  49. 49.
    R.J. Hay, R.A. Calderas, and M.I. Collins, Experimental dermatophytosis, J Invest Derm. 81:270–274 (1985)CrossRefGoogle Scholar
  50. 50.
    H.E. Jones, Animal models of human dermatophyte infection, in: Animal Models in Dermatology, pp 168–175, Maibach ed., Churchill Livingstone, Edimburg (1975)Google Scholar
  51. 51.
    P.E. Pochi, Sebaceous gland assay, in: Models in Dermatology; vol 2, pp 70–75, Maibach, Lowe eds., Karger, Basel (1985)Google Scholar
  52. 52.
    A. Weissmann, J. Bowden, B. Frank, S.N. Horwitz, and P. Frost, Morphometric studies of the hamster flask organ: an improved model to evaluate pharmacologic effects on sebaceous glands, J Invest Dermatol. 82:522–525 (1984)PubMedCrossRefGoogle Scholar
  53. 53.
    K. Motoyoshi, Whole Mount Technique: an improved hamster ear model to evaluate pharmacologic effects on sebaceous glands, J Dermatol. 15:252–256 (1988)PubMedGoogle Scholar
  54. 54.
    S.M. Puhvel, Animal models for comedolytic agents, in: Models in Dermatology, vol 2, pp 64–69, Maibach, Lowe eds., Karger, Basel (1985)Google Scholar
  55. 55.
    J.A. Mezick, M.C. Bhatia, L.M. Shea, E.G. Thorne, and R.J. Capetola, Anti-acne activity of retinoids in the rhinomouse, in: Models in Dermatology, vol 2, pp 59–63, Maibach, Lowe eds., Karger, Basel (1985)Google Scholar
  56. 56.
    A. Barbier, C. Planchenault, C. Vernhet, and J.C. Breliere, Dermatosis in magnesium-deficient hairless rats: effects of steroidal and non-steroidal anti-inflammatory drugs, Agents Actions, 17:352–354 (1986)PubMedCrossRefGoogle Scholar
  57. 57.
    J.H. Saurat, P. Chavaz, A. Barbier, and F. Fancher, Dermatosis in hairless rats fed a low magnesium diet, in: Models in Dermatology, vol 1, pp 202–209, Maibach, Lowe eds., Karger, Basel (1985)Google Scholar
  58. 58.
    P.M. Elias, The essential fatty acid deficient rodent: Evidence for a direct role for intercellular lipid in barrier function, in: Models in Dermatology, pp 272–285, Maibach H.I., Lowe N.J. eds., Karger, Basel (1985)Google Scholar
  59. 59.
    N.J. Lowe, and R.B. Stoughton, Essential fatty acid deficient hairless mouse. A model of chronic epidermal hyperproliferation, Br J Dermatol. 96:155–162 (1977)PubMedCrossRefGoogle Scholar
  60. 60.
    P.M. Elias, M.L. Williams, M.E. Maloney, P.O. Fritsh, and J.C. Chung, Drug-induced animal models of ichthyosis, in: Models in Dermatology, vol 1, pp 105–126, Maibach, Lowe eds., Karger, Basel (1985)Google Scholar
  61. 61.
    L.A. Goldsmith, Genetic Models of ichthyosis, in: Models in Dermatology, vol 1, pp 127–131, Maibach, Lowe eds., Karger, Basel (1985)Google Scholar
  62. 62.
    W.R. Brown, and M.H. Hardy, The Asebia mouse: an animal model of psoriasiform disease, in: Models in Dermatology, vol 1, pp 220–227, Maibach, Lowe eds., Karger, Basel (1985)Google Scholar
  63. 63.
    K.E. Black, W.W. Jederberg, Athymic nude mice and human skin grafting, in: Models in Dermatology, vol 1, pp 228–239, Maibach, Lowe eds., Karger, Basel (1985)Google Scholar
  64. 64.
    M.A.B. De Sousa, and J. Fachet, The cellular basis of the mechanism of action of cortisone acetate on contact sensitivity to oxazolone in the mouse, Clin Exp Immunol. 10:673–684 (1972)PubMedGoogle Scholar
  65. 65.
    D.P. Evans, M. Hossack, and D.S. Thomson, Inhibition of contact sensitivity in topical application of corticosteroids, Br J Pharmacol. 43:403–408 (1971)PubMedGoogle Scholar
  66. 66.
    A. Howard, “Rhino” an allele of hairless in the house mouse, J Hered. 31:467–470 (1941)Google Scholar
  67. 67.
    E.G. Van Scott, Experimental animal integumental models for screening potential dermatologic drugs, in: Pharmacology and the Skin. Advances in biology of skin, vol 12, pp 523–533, Montagna, Van Scott, Stougnton eds., Appleton, Century, Crafts, New York (1972)Google Scholar
  68. 68.
    L.H. Kligman, and A.M. Kligman, The effect on rhino mouse skin of agents which influence keratinization and exfoliation, J Invest Derm. 73:354–358 (1979)PubMedCrossRefGoogle Scholar
  69. 69.
    O.H. Mills and A.M. Kligman, Assay of comedolytic agents in the rabbit ear, in: Animal Models in Dermatology, pp 176–183, Maibach ed., Churchill, Livingstone, Edimburg (1975)Google Scholar
  70. 70.
    R.J. Trancik, Topical non-steroidal anti-inflammatory agents, in: Recent Advances in: Dermato Pharmacology, pp 133–147, Frost, Gomez, Zaias eds., New York, Spectrum (1977)Google Scholar
  71. 71.
    J.V. Christiansen, E. Gadborg and I. Kleiter, Efficacy of Bufexamac (NFN) cream in skin disease, Dermatoloqica 154: 177–184 (1977)CrossRefGoogle Scholar
  72. 72.
    M. Bouclier, B. Luginbuhl, F. Delamadeleine, P. Rossio and C. Hensby, Repeated application of arachidonic acid to the ear of mice: A model of chronic skin inflammation? Agents Actions 26: 227–228 (1989)PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Martine Bouclier
    • 1
  • Christopher N. Hensby
    • 1
  • Daniel Cavey
    • 1
  1. 1.CIRD (Centre International de Recherches Dermatologiques)ValbonneFrance

Personalised recommendations